By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Prima Biomed 

Unit 7, 79 - 83 High Street

Melbourne  Victoria  3101  Australia
Phone: 61-3-9854-5700 Fax: 61-3-9854-5777



Company News
Prima Biomed (PRR.AX) Release: CVac™ CAN-003 Abstract Accepted For Poster Presentation At The Society For Immunotherapy Of Cancer Annual Meeting 8/19/2014 10:10:16 AM
Prima Biomed (PRR.AX) Receives U.S. Patent Grant For CVac 7/16/2014 10:26:01 AM
Prima Biomed (PRR.AX) Appoints New Chief Executive Officer 7/9/2014 8:11:13 AM
Prima Biomed (PRR.AX)'s CAN-002 CVac™ Trial Published In Journal For ImmunoTherapy Of Cancer 6/23/2014 8:15:45 AM
Prima Biomed (PRR.AX) To Present At WAGO Annual Meeting In California 6/19/2014 12:55:58 PM
Prima Biomed (PRR.AX) To Host Conference Call To Discuss Abstract Presented At American Society of Clinical Oncology On New Interim Overall Survival And Final Progression Free Survival Data For The Company's CAN-003 Trial 6/2/2014 10:50:00 AM
Prima Biomed (PRR.AX)'s CVac Patent Application Receives U.S. Notice Of Allowance 5/27/2014 9:04:26 AM
Prima Biomed (PRR.AX)'s CVac™ Granted Fast Track Designation By FDA 5/9/2014 9:03:15 AM
Prima Biomed (PRR.AX) Third Quarter Conference Call 4/29/2014 11:03:02 AM
Prima Biomed (PRR.AX)'s CAN-004 Phase 2 Trial For Cvac™ Commences Recruitment 4/28/2014 9:51:11 AM